All In Biotech

Drug Trial Radar · NCT06752590

A Clinical Study of ONO-1110 in Patients With Fibromyalgia

A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients With Fibromyalgia

Last checked: Nov 19, 2026Latest source record: Jul 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 175 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

175

Actual

Start

Mar 26, 2025

Primary completion

May 30, 2026

Study completion May 30, 2026

Sponsor

Lead sponsor
Ono Pharmaceutical Co., Ltd.Industry
Sponsor type
Industry
First posted
Dec 30, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Fibromyalgia

Conditions

  • Fibromyalgia

Interventions

  • ONO-1110Drug

    ONO-1110 tablets once a day

  • PlaceboDrug

    Placebo tablets once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in weekly mean of average pain score from baseline to Week 8 of the treatment periodTime frame: Up to 16 weeks
  2. Adverse eventsTime frame: Up to 16 weeks

Locations

30 sites in 1 country. Site status is shown where the registry gives one.

  • Kyushu University Hospital

    Fukuoka, Japan

  • Yakushinkai Healthcare Association Kandasudacho Dermatology

    Tokyo, Japan

  • Aichi Medical University Hospital

    Nagakute, Aichi-ken, Japan

  • Kimura Clinic

    Nagoya, Aichi-ken, Japan

  • National Hospital Organization Shimoshizu National Hospital

    Yotsukaidō, Chiba, Japan

  • Ai Sakura Clinic

    Fukuoka, Fukuoka, Japan

  • Sapporo City General Hospital

    Sapporo, Hokkaido, Japan

  • Mayflower Hospital

    Katō, Hyōgo, Japan

  • Shirasawa Orthopedic Clinic

    Morioka, Iwate, Japan

  • Kokorotoitami Clinic

    Kawasaki, Kanagawa, Japan

  • Women's Clinic Luna

    Yokohama, Kanagawa, Japan

  • Junwakai Memorial Hospital

    Miyazaki, Miyazaki, Japan

  • Miyashita Rheumatology Clinic

    Ōmura, Nagasaki, Japan

  • Medical Corporation Fujigaki Clinic

    Ōita, Oita Prefecture, Japan

  • Japanese Red Cross Okayama Hospital

    Okayama, Okayama-ken, Japan

  • Hayaishi Hospital

    Osaka, Osaka, Japan

  • Morimoto Clinic

    Osaka, Osaka, Japan

  • Shizuoka Rehab Pain Clinic

    Shizuoka, Shizuoka, Japan

  • Fukuwa Clinic

    Tokyo, Tokyo, Japan

  • Ginza Neurological Clinic

    Tokyo, Tokyo, Japan

  • Himenotomomi Clinic

    Tokyo, Tokyo, Japan

  • Ikebukuro Internal Medicine

    Tokyo, Tokyo, Japan

  • Juntendo Tokyo Koto Geriatric Medical Center

    Tokyo, Tokyo, Japan

  • Juntendo University Hospital

    Tokyo, Tokyo, Japan

  • Juntendo University Nerima Hospital

    Tokyo, Tokyo, Japan

  • Nihonbashi Medical

    Tokyo, Tokyo, Japan

  • Nishiogi Pain Clinic

    Tokyo, Tokyo, Japan

  • Sanno Hospital

    Tokyo, Tokyo, Japan

  • Tokyo-Eki Center-Building Clinic

    Tokyo, Tokyo, Japan

  • Toyama University Hospital

    Toyama, Toyama, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.